RxDoctor Payments Data

Jayanthi Koneru, MD

Clinical Cardiac Electrophysiology · Richmond, VANPI 1760682512

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (30.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 29.8% of the total. Reporting peaked in 2022 at $21,419 and has fallen 76.1% since, to $5,121 in 2025.

$61,878in general payments, 2019–2025

Across 213 payments — averaging $290.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$18K
  • Abbott$12K
  • Biosense Webster, Inc.$11K
  • Boston Scientific$11K
  • Biotronik Inc.$7K
  • Medical Device Business Services, Inc.$2K
  • plus $584 from 7 others
$321,486in research payments, 2019–2025

Across 91 payments — averaging $3532.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$136K
  • Medtronic$114K
  • Medical Device Business Services, Inc.$48K
  • Recor Medical Inc$23K

What the payments were for

  • Consulting fees$18,87531%
  • Speaking & faculty fees$18,41330%
  • Travel & lodging$18,38330%
  • Food & beverage$6,20810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,878 in reported general payments places this provider in the 80th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia

Medicare billing

Part B allowed, 2024
$280,847
Medicare patients
1,464
Services billed
2,576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban115$130,767
XareltoRivaroxaban46$47,723
Dofetilide43$7,402
Amiodarone Hcl22$1,439
Metoprolol Succinate53$624
Flecainide Acetate19$600
Metoprolol Tartrate14$275
Potassium Chloride15$60
Amlodipine Besylate20$29

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →